Results 111 to 120 of about 630,325 (166)

Functional Profiling of Acetylcholine Receptor Antibodies Informs Therapeutic Outcome of FcRn Inhibitor Therapy in Myasthenia Gravis. [PDF]

Neurol Neuroimmunol Neuroinflamm
Morcone V, Morroni J, Valenzano G, Marini S, Falso S, Marini M, Habetswallner F, Farì G, Carrozza C, Iorio R.   +9 more
europepmc   +1 more source

The MHC class I-related FcRn ameliorates murine Lyme arthritis.

, 2006
The identification of the neonatal FcR (FcRn) as an IgG homeostasis regulator has led to research aimed at delineating a role for FcRn in humorally mediated disease.
Sproule, T J, Roopenian, D, Crowley, H, Huber, B T, Alroy, J   +4 more
core  

Expression of FcRn receptor and pharmacokinetics of monoclonal antibodies

, 2014
Le FcRn est le récepteur responsable du recyclage des IgG ainsi que de leur transcytose. Ainsi cette protéine a un rôle majeur dans la pharmacocinétique des anticorps thérapeutiques.
Passot, Christophe
core  

Clinical Course After a Single Cycle of Rozanolixizumab in Generalized Late-Onset Myasthenia Gravis. [PDF]

J Clin Neurol
Aritake S, Nagai A.
europepmc   +1 more source

Age and Treatment Efficacy in Myasthenia Gravis: A Systematic Review, Meta-Analysis, and Meta-Regression. [PDF]

Eur J Neurol
Nelke C, Skrobol M, Theissen L, Sacca F, Ruck T.   +4 more
europepmc   +1 more source

FcRn Inhibition in Autoantibody-Mediated Autoimmune Diseases: From Broad Immunosuppression to Precision IgG Modulation. [PDF]

Mediterr J Rheumatol
Chrousos GP, Skopouli FN, Moutsopoulos HM.   +2 more
europepmc   +1 more source

Research Progress in Pharmacological Targeted Therapy for Myasthenia Gravis. [PDF]

J Inflamm Res
Zhou Y, Wu Y, Meng Z.
europepmc   +1 more source

Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions With the Antibody-Drug Conjugate Trastuzumab Deruxtecan. [PDF]

CPT Pharmacometrics Syst Pharmacol
Watanabe A, Gill KL, Chen KF, Jones HM, De Sousa Mendes M, Gardner I, Kotsuma M.   +6 more
europepmc   +1 more source

Editorial: Case reports in autoimmune and autoinflammatory disorders, volume II. [PDF]

Front Immunol
Wincup C, Ghiggeri GM.
europepmc   +1 more source

B Cells and B Cell Depletion in Autoimmunity and Atherosclerosis. [PDF]

Life (Basel)
Solomon JL, Dubbaka A, Srivastava A, Belilos E, Leon J, Carsons SE, Reiss AB.   +6 more
europepmc   +1 more source